Center for Infectious Diseases, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, Japan.
J Infect Chemother. 2015 Feb;21(2):134-7. doi: 10.1016/j.jiac.2014.08.010. Epub 2014 Oct 16.
Chronic invasive aspergillosis of the sinus is frequently fatal in the absence of early surgical and chemotherapeutic intervention because of its invasion of vascular tissue. We attempted to control a case of inoperable invasive aspergillosis of the sinus with micafungin and itraconazole oral solution. We prescribed a daily oral dose of 400 mg of itraconazole, which is twice the usual dose, and monitored the serum concentration of the drug. Finally, we were able to control the spread of the lesion. This case indicates that combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution is an alternative treatment strategy for inoperable invasive aspergillosis of the sinus.
慢性侵袭性鼻窦曲霉病由于侵犯血管组织,如果不进行早期手术和化疗干预,通常会致命。我们尝试用米卡芬净和伊曲康唑口服液来控制一例无法手术的侵袭性鼻窦曲霉病。我们规定了每天口服 400 毫克伊曲康唑,这是通常剂量的两倍,并监测药物的血清浓度。最后,我们成功地控制了病变的扩散。本病例表明,米卡芬净联合每天 400 毫克伊曲康唑口服液的联合治疗是治疗无法手术的侵袭性鼻窦曲霉病的一种替代治疗策略。